Page 39 - Marcus News Today

Macy’s will close 150 stores over the next three years and 50 by the end of 2024, the department store said Tuesday after posting a fourth quarter loss and decl

Profund Advisors LLC lessened its holdings in Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 51,071 shares of the company’s stock after selling 5,325 shares during the quarter. Profund Advisors LLC […]

On Tuesday’s Trending With Marcus on the WGN Morning News, Marcus Leshock gives a look at the trailer that just dropped for Kevin Costner’s upcoming Western epic. Costner’s four-part epic, “Horizon: An American Saga,” will debut in theaters this summer with a dual release of the first two parts. Chapter 1 is scheduled to hit […]

Wedbush reiterated their outperform rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a research report sent to investors on Thursday, Marketbeat Ratings reports. The brokerage currently has a $30.00 target price on the stock. Wedbush also issued estimates for Arcus Biosciences’ FY2028 earnings at $1.87 EPS. A number of other research analysts […]

Wedbush reiterated their outperform rating on shares of Arcus Biosciences (NYSE:RCUS – Free Report) in a research note released on Thursday, MarketBeat reports. Wedbush currently has a $30.00 price objective on the stock. Wedbush also issued estimates for Arcus Biosciences’ FY2028 earnings at $1.87 EPS. Other equities analysts have also recently issued research reports about […]

The Marcus Co. (NYSE:MCS – Get Free Report) declared a quarterly dividend on Thursday, February 22nd, Wall Street Journal reports. Shareholders of record on Monday, March 4th will be given a dividend of 0.07 per share on Friday, March 15th. This represents a $0.28 annualized dividend and a yield of 1.91%. The ex-dividend date of […]

Arcus Biosciences (NYSE:RCUS – Get Free Report) released its earnings results on Wednesday. The company reported ($1.08) EPS for the quarter, beating the consensus estimate of ($1.09) by $0.01, Briefing.com reports. Arcus Biosciences had a negative net margin of 262.39% and a negative return on equity of 54.63%. The company had revenue of $31.00 million […]

Editor’s Note: If you are interested in adopting one of these animals, please check with the shelter or rescue to be sure the animal is still available.

Citigroup Inc. increased its holdings in Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) by 20.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 145,729 shares of the company’s stock after buying an additional 25,083 shares during the quarter. Citigroup Inc. […]

Arcus Biosciences (NYSE:RCUS – Get Free Report) issued its earnings results on Wednesday. The company reported ($1.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.09) by $0.01, Briefing.com reports. The company had revenue of $31.00 million for the quarter, compared to analysts’ expectations of $28.30 million. Arcus Biosciences had a […]